Luca Scavo
2021
In 2021, Luca Scavo earned a total compensation of $3.9M as Chief Financial Officer at Evelo Biosciences.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $82,250 |
| Option Awards | $3,184,290 |
| Salary | $415,000 |
| Stock Awards | $64,721 |
| Other | $98,512 |
| Total | $3,894,773 |
Scavo received $3.2M in option awards, accounting for 82% of the total pay in 2021.
Scavo also received $50K in bonus, $82.3K in non-equity incentive plan, $415K in salary, $64.7K in stock awards and $98.5K in other compensation.
Rankings
In 2021, Luca Scavo's compensation ranked 3,436th out of 12,415 executives tracked by ExecPay. In other words, Scavo earned more than 72.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,436 out of 12,415 | 72nd |
Division Manufacturing | 1,400 out of 5,508 | 75th |
Major group Chemicals And Allied Products | 566 out of 2,378 | 76th |
Industry group Drugs | 504 out of 2,099 | 76th |
Industry Pharmaceutical Preparations | 351 out of 1,549 | 77th |
Source: SEC filing on April 26, 2022.
Scavo's colleagues
We found two more compensation records of executives who worked with Luca Scavo at Evelo Biosciences in 2021.